Treats partial seizures. ANDA 77555, held by Sun Pharm Inds. Tiagabine Hydrochloride.
As of Nov 16, 2026, ANDA 77555 (Tiagabine Hydrochloride), held by Sun Pharm Inds, was first approved by FDA on Nov 4, 2011, with 0 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Tiagabine hydrochloride tablets are indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 4, 2011 | Original application | Approved |
| Tiagabine Hydrochloride2MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
| Tiagabine Hydrochloride4MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters